Clinical Trial Update: Hypofractionated Radiotherapy for Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating hypofractionated radiotherapy for small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Lung Neoplasm, Small Cell Carcinoma | Phase 1 | Status: COMPLETED